Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Circulatory changes during the reversal of experimental hypertension.

LEDINGHAM JM, COHEN RD.

Clin Sci. 1962 Feb;22:69-77. No abstract available.

PMID:
14463438
2.

General and regional haemodynamic pattern underlying essential hypertension.

BROD J, FENCL V, HEJL Z, JIRKA J, ULRYCH M.

Clin Sci. 1962 Oct;23:339-49. No abstract available.

PMID:
14015642
3.

Cardiac abnormalities in end stage renal failure and anaemia.

Morris KP, Skinner JR, Wren C, Hunter S, Coulthard MG.

Arch Dis Child. 1993 May;68(5):637-43.

4.

Hemodynamic responses to oxygen breathing in children with severe anemia.

Cropp GJ.

Circulation. 1969 Oct;40(4):493-500. No abstract available.

PMID:
5823546
5.

Hemodynamics of uremic anemia.

Neff MS, Kim KE, Persoff M, Onesti G, Swartz C.

Circulation. 1971 Jun;43(6):876-83. No abstract available.

PMID:
4931294
6.

Reproducibility of cardiac output measurement by cross sectional and Doppler echocardiography.

Robson SC, Murray A, Peart I, Heads A, Hunter S.

Br Heart J. 1988 Jun;59(6):680-4.

8.

Hemodynamics of patients with renal failure treated with recombinant human erythropoietin.

Verbeelen D, Bossuyt A, Smitz J, Herman A, Dratwa M, Jonckheer MH.

Clin Nephrol. 1989 Jan;31(1):6-11.

PMID:
2914412
9.

Vascular changes in hemodialysis patients in response to recombinant human erythropoietin.

London GM, Zins B, Pannier B, Naret C, Berthelot JM, Jacquot C, Safar M, Drueke TB.

Kidney Int. 1989 Nov;36(5):878-82.

10.

Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin.

Löw I, Grützmacher P, Bergmann M, Schoeppe W.

Clin Nephrol. 1989 Jan;31(1):26-30.

PMID:
2521587
11.

Seizures in haemodialysis patients treated with recombinant human erythropoietin.

Edmunds ME, Walls J, Tucker B, Baker LR, Tomson CR, Ward M, Cunningham J, Moore R, Winearls CG.

Nephrol Dial Transplant. 1989;4(12):1065-9.

PMID:
2517327
12.

Long-term effects of treatment with recombinant human erythropoietin on haemodynamics and tissue oxygenation in patients with renal anaemia.

Nonnast-Daniel B, Deschodt G, Brunkhorst R, Creutzig A, Bahlmann J, Shaldon S, Koch KM.

Nephrol Dial Transplant. 1990;5(6):444-8.

PMID:
2122322
13.

Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients.

Cannella G, La Canna G, Sandrini M, Gaggiotti M, Nordio G, Movilli E, Maiorca R.

Clin Nephrol. 1990 Dec;34(6):272-8.

PMID:
2073771
14.
15.

Hemodynamic changes in hemodialyzed patients during treatment with recombinant human erythropoietin.

Teruel JL, Pascual J, Jiménez M, Liaño F, Rivera M, Martínez J, Moya JL, Ortuño J.

Nephron. 1991;58(2):135-7.

PMID:
1865967
16.

Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.

Pascual J, Teruel JL, Moya JL, Liaño F, Jiménez-Mena M, Ortuño J.

Clin Nephrol. 1991 Jun;35(6):280-7.

PMID:
1831414

Supplemental Content

Support Center